(BPT) - If you are one of the more than 35 million Americans who are estimated to have obstructive sleep apnea (OSA), you already know how disruptive it can be
(BPT) - If you are one of the more than 35 million Americans who are estimated to have obstructive sleep apnea (OSA), you already know how disruptive it can be
American Journal of Respiratory and Critical Care Medicine Publishes Full, Positive Results of Apnimed's MARIPOSA Study on AD109, an Investigational Oral Drug for Obstructive Sleep Apnea streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Fresh off reporting its MARIPOSA Phase 2b study findings, Apnimed’s clinical development lead says the company plans to test its OSA drug candidates in two longer clinical trials.